Clinical Trial Update: FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 study comparing FOLFIRI against Irinotecan as second-line treatment for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Carcinoma | Phase 3 | Status: UNKNOWN